Tumor Blood Vessels Orchestrate The Birth Of Cancer Stem Cells

Like blood vessels that supply oxygen and nutrients to normal tissue, tumor blood vessels were originally thought to do likewise to fuel tumor growth. As scientists developed strategies to kill tumors by cutting off their blood supply, they soon discovered their valiant efforts were thwarted by the tumor's ability to quickly recover. The recovery is caused by a population of tumor-initiating cancer cells dubbed the cancer stem cells (CSCs); a population that can communicate with blood vessels via the Notch signaling pathway to drive tumor vascularization.

Like blood

vessels that supply oxygen and nutrients to normal tissue, tumor blood vessels

were originally thought to do likewise to fuel tumor growth. As scientists

developed strategies to kill tumors by cutting off their blood supply, they

soon discovered their valiant efforts were thwarted by the tumor's ability to

quickly recover.

The recovery is caused by a population of tumor-initiating

cancer cells dubbed the cancer stem cells (CSCs); a population that can

communicate with blood vessels via the Notch signaling pathway to drive tumor

vascularization.

It turns

out that this "Notch" communication can go both ways. In a Cancer Cell study, scientists discovered that

tumor-blood vessels can communicate with cancer cells via Notch signaling,

and direct their transformation into cancer stem cells. Specifically, the

authors found that when colorectal cancer cells are exposed to tumor

endothelial cell directly or indirectly via conditioned medium, these cells

acquire features that resemble CSCs.

Some of these features include their

expression of the stem cell marker CD133, their ability to initiate colorectal

cancer when transplanted elsewhere, and their marked resistance to

chemotherapy.

The authors

further found that the Notch signaling is driven by the release of soluble

Jagged-1 from the surface of endothelial cells, a process driven by a membrane

enzyme ADAM17. Jagged-1 binds to Notch-1 and triggers downstream activation of

the transcription factors Hes1 and NICD in cancer cells to drive their

transformation into CSCs.  

Supporting

this preclinical data, the authors found that colorectal CSCs are closely

associated tumor blood vessels in clinical surgical specimens of colorectal

cancer. Using a Notch signaling reporter system to track Hes1 and NICD in

surgical specimens, the authors were able to confirm that Notch signaling is

indeed active in colorectal cancer cells/stem cells surrounding tumor blood

vessels.

This study first

evidence suggesting that tumor-blood vessels are not merely conduits of

nutrients and oxygen, but are also a communication hub that orchestrates the

birth of cancer stem cells- the drivers of tumor initiation.

Reference:

Lu et al., Endothelial Cells Promote the Colorectal Cancer

Stem Cell Phenotype through a Soluble Form of Jagged-1, Cancer Cell (2013),

http://dx.doi.org/10.1016/j.ccr.2012.12.021

Old NID
102767
Categories

Latest reads

Article teaser image
Donald Trump does not have the power to rescind either constitutional amendments or federal laws by mere executive order, no matter how strongly he might wish otherwise. No president of the United…
Article teaser image
The Biden administration recently issued a new report showing causal links between alcohol and cancer, and it's about time. The link has been long-known, but alcohol carcinogenic properties have been…
Article teaser image
In British Iron Age society, land was inherited through the female line and husbands moved to live with the wife’s community. Strong women like Margaret Thatcher resulted.That was inferred due to DNA…